PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28337024-0	2017	Angiotensin II promotes the anticoagulant effects of rivaroxaban via angiotensin type 2 receptor signaling in mice.	Rivaroxaban	53-64	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	0-14	
28337024-4	2017	In this study, we investigate whether AngII influences anticoagulant effects of rivaroxaban by using an experimental mouse model with type 2 diabetes mellitus and advanced glycation end product (AGE)-exposed human umbilical vein endothelial cells (HUVECs).	Rivaroxaban	80-91	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	38-43	
28337024-5	2017	We found that AngII promoted the anticoagulant effects of rivaroxaban in KKAy mice.	Rivaroxaban	58-69	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	14-19	
28337024-7	2017	Angiotensin type 2 receptor (AT2R) and Mas antagonists attenuated the AngII-enhanced anticoagulant action of rivaroxaban in vivo, and abolished the increased endothelial TFPI expression and activity.	Rivaroxaban	109-120	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	70-75	
28337024-10	2017	Our data suggest that the anticoagulant effects of rivaroxaban are promoted by AngII via AT2R and Mas signaling.	Rivaroxaban	51-62	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	79-84	
32521334-0	2020	Rivaroxaban ameliorates angiotensin II-induced cardiac remodeling by attenuating TXNIP/Trx2 interaction in KKAy mice.	Rivaroxaban	0-11	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	24-38	
32521334-2	2020	Based on those previous research results, we detected the roles of Rivaroxaban in Angiotensin II (AngII)-induced cardiac remodeling with KKAy mice and unraveled the underlying mechanisms.	Rivaroxaban	67-78	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	82-96	
32521334-2	2020	Based on those previous research results, we detected the roles of Rivaroxaban in Angiotensin II (AngII)-induced cardiac remodeling with KKAy mice and unraveled the underlying mechanisms.	Rivaroxaban	67-78	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	98-103	
32521334-3	2020	Rivaroxaban inhibited cardiac fibrosis and hypertrophy in AngII-infused KKAy mice.	Rivaroxaban	0-11	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	58-63	
32521334-9	2020	Thus, Rivaroxaban ameliorates AngII-induced cardiac remodeling via the suppression of TXNIP signaling in KKAy mice, providing novel mechanism underlying the protective roles of Rivaroxaban against cardiac damage.	Rivaroxaban	6-17	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	30-35	
32521334-9	2020	Thus, Rivaroxaban ameliorates AngII-induced cardiac remodeling via the suppression of TXNIP signaling in KKAy mice, providing novel mechanism underlying the protective roles of Rivaroxaban against cardiac damage.	Rivaroxaban	177-188	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	30-35